C. Trépo

14.8k total citations · 4 hit papers
200 papers, 11.2k citations indexed

About

C. Trépo is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, C. Trépo has authored 200 papers receiving a total of 11.2k indexed citations (citations by other indexed papers that have themselves been cited), including 157 papers in Hepatology, 156 papers in Epidemiology and 27 papers in Infectious Diseases. Recurrent topics in C. Trépo's work include Hepatitis C virus research (143 papers), Hepatitis B Virus Studies (127 papers) and Liver Disease Diagnosis and Treatment (83 papers). C. Trépo is often cited by papers focused on Hepatitis C virus research (143 papers), Hepatitis B Virus Studies (127 papers) and Liver Disease Diagnosis and Treatment (83 papers). C. Trépo collaborates with scholars based in France, United States and Germany. C. Trépo's co-authors include Henry Lik‐Yuen Chan, Anna S. Lok, Janice K. Albrecht, Thierry Poynard, Fabien Zoulim, Patrick Marcellin, Stefan Zeuzem, Samuel S. Lee, Christian Niederau and Gerald Minuk and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

C. Trépo

197 papers receiving 10.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

1998 1.9k citations Patrick Marcellin, C. Trépo et al. profile →
Hepatitis B virus infection

2014 1.2k citations C. Trépo et al. profile →
Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C

2002 849 citations Michael P. Manns, C. Trépo et al. profile →
THE e ANTIGEN AND VERTICAL TRANSMISSION OF HEPATITIS B SURFACE ANTIGEN

1977 466 citations C. Trépo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Trépo France	46	9.4k	9.1k	1.2k	737	721	200	11.2k
Christian Trépo France	52	9.0k 1.0×	9.4k 1.0×	2.0k 1.6×	768 1.0×	687 1.0×	275	12.9k
Sugantha Govindarajan United States	55	7.9k 0.8×	6.7k 0.7×	2.0k 1.6×	797 1.1×	439 0.6×	180	10.4k
Johnson Y.N. Lau United States	44	6.6k 0.7×	6.1k 0.7×	771 0.6×	537 0.7×	772 1.1×	134	8.2k
Ola Weiland Sweden	47	7.6k 0.8×	7.2k 0.8×	1.5k 1.2×	611 0.8×	855 1.2×	254	9.2k
Patrizia Farci Italy	50	9.2k 1.0×	8.6k 1.0×	982 0.8×	653 0.9×	543 0.8×	153	10.9k
Ferruccio Bonino Italy	56	14.2k 1.5×	14.0k 1.5×	1.4k 1.2×	1.0k 1.4×	735 1.0×	329	17.0k
David R. Gretch United States	53	9.1k 1.0×	7.9k 0.9×	1.0k 0.8×	1.7k 2.3×	1.6k 2.3×	142	12.4k
Robert P. Perrillo United States	44	8.4k 0.9×	8.9k 1.0×	1.0k 0.8×	366 0.5×	621 0.9×	119	10.1k
Geoffrey Dusheiko United Kingdom	60	15.1k 1.6×	14.6k 1.6×	2.4k 2.0×	1.6k 2.1×	915 1.3×	285	18.6k
Christoph Sarrazin Germany	60	10.8k 1.2×	10.4k 1.1×	2.5k 2.0×	695 0.9×	897 1.2×	329	13.8k

Countries citing papers authored by C. Trépo

Since Specialization

Citations

This map shows the geographic impact of C. Trépo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Trépo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Trépo more than expected).

Fields of papers citing papers by C. Trépo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Trépo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Trépo. The network helps show where C. Trépo may publish in the future.

Co-authorship network of co-authors of C. Trépo

This figure shows the co-authorship network connecting the top 25 collaborators of C. Trépo. A scholar is included among the top collaborators of C. Trépo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Trépo. C. Trépo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Loustaud‐Ratti, V., Paul Carrier, Annick Rousseau, et al.. (2011). Pharmacological exposure to ribavirin: A key player in the complex network of factors implicated in virological response and anaemia in hepatitis C treatment. Digestive and Liver Disease. 43(11). 850–855. 12 indexed citations

Manns, Michael P., Marc Bourlière, Yves Benhamou, et al.. (2010). Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection. Journal of Hepatology. 54(6). 1114–1122. 89 indexed citations

Dumortier, Jérôme, Rodica Gincul, J Baulieux, et al.. (2008). Long-term results of liver transplantation for Wilson's disease. Gastroentérologie Clinique et Biologique. 32(4). 378–381. 14 indexed citations

Garcia, Céline, Birke Bartosch, Nicole Zitzmann, et al.. (2006). Glucosidase inhibitors induce HCV glycoproteins misfolding, impair viral assembly and release, and reduce the infectivity of residually secreted HCV particles. Hepatology. 44. 1 indexed citations

Walter, Thomas, et al.. (2004). Lymphome non hodgkinien primitif du foie chez un patient infecté par le VIH : à propos d'une observation. La Revue de Médecine Interne. 25(8). 596–600. 4 indexed citations

Trépo, C., Marianne Maynard, & Fabien Zoulim. (2003). Perspectives on therapy of hepatitis B. Journal of Hepatology. 39. 220–223. 10 indexed citations

Chemin, Isabelle, Fabien Zoulim, Philippe Merle, et al.. (2001). High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. Journal of Hepatology. 34(3). 447–454. 141 indexed citations

Dumortier, Jérôme, T Bizollon, Jean‐Yves Scoazec, et al.. (2001). Orthotopic Liver Transplantation for Idiopathic Portal Hypertension: Indications and Outcome. Scandinavian Journal of Gastroenterology. 36(4). 417–422. 29 indexed citations

Pradat, Pierre & C. Trépo. (2000). HCV: epidemiology, modes of transmission and prevention of spread. Best Practice & Research Clinical Gastroenterology. 14(2). 201–210. 34 indexed citations

10.

Bizollon, T, Christian Ducerf, C. Trépo, & David Mutimer. (1999). Hepatitis C virus recurrence after liver transplantation. Gut. 44(4). 575–578. 50 indexed citations

11.

Bizollon, T, Christian Ducerf, J Baulieux, & C. Trépo. (1999). Treatment of recurrent hepatitis C following liver transplantation. Current Gastroenterology Reports. 1(1). 15–19. 4 indexed citations

12.

Krogsgaard, Kim, Patrick Marcellin, C. Trépo, et al.. (1998). [Pretreatment with prednisolone enhances the effect of human lymphoblastoid interferon in chronic hepatitis B].. PubMed. 160(39). 5657–61. 2 indexed citations

13.

Sunyach, Claire, et al.. (1997). In VivoSelection of Duck Hepatitis B Virus Pre-S Variants Which Escape from Neutralization. Virology. 234(2). 291–299. 9 indexed citations

14.

Trabaud, Mary‐Anne, François Bailly, Giuseppe Colucci, & C. Trépo. (1996). Stability of hepatitis C virus RNA in serum from samples collected in a closed‐tube system for serum separation and transport, as measured by a quantitative competitive PCR assay. Journal of Viral Hepatitis. 3(4). 207–209. 7 indexed citations

15.

Lerat, Hervé, Françoise Berby, Mary‐Anne Trabaud, et al.. (1996). Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells.. Journal of Clinical Investigation. 97(3). 845–851. 228 indexed citations

16.

Krogsgaard, Kim, Niels Bindslev, Erik Christensen, et al.. (1994). The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. Journal of Hepatology. 21(4). 646–655. 70 indexed citations

17.

Trépo, C., Fabien Zoulim, Cristina Alonso, et al.. (1993). Diagnostic markers of viral hepatitis B and C.. Gut. 34(2 Suppl). S20–S25. 20 indexed citations

18.

Escaich, Sonia, et al.. (1992). Relevance of the Quantitative Detection of HIV Proviral Sequences in PBMC of Infected Individuals. AIDS Research and Human Retroviruses. 8(10). 1833–1837. 23 indexed citations

19.

Fourel, Isabelle, Philippe Gripon, O. Hantz, et al.. (1989). Prolonged duck hepatitis B virus replication in duck hepatocytes cocultivated with rat epithelial cells: A useful system for antiviral testing. Hepatology. 10(2). 186–191. 29 indexed citations

20.

Granato, Celso, et al.. (1987). An ELISA method using serum derived HDAg for the sorological detection of HDV antigens and antibodies. Revista do Instituto de Medicina Tropical de São Paulo. 29(6). 388–391. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact